| Name | 3-Fluoro-4-{[hydroxy(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-nap hthalenyl)acetyl]amino}benzoic acid |
|---|---|
| Synonyms |
3-FLUORO-4-[(R)-2-HYDROXY-2-(5,5,8,8-TETRAMETHYL-5,6,7,8-TETRAHYDRO-NAPHTHALEN-2-YL)-ACETYLAMINO]-BENZOIC ACID
(R)-3-Fluoro-4-(2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)acetamido)b 3-Fluoro-4-[[2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8,-tetrahydro-2-naphthalenyl)acetyl]amino]-benzoic acid Benzoic acid, 3-fluoro-4-[[2-hydroxy-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)acetyl]amino] 3-FLUORO-4-[2-HYDROXY-2-(5,5,8,8-TETRAMETHYL-5,6,7,8-TETRAHYDRO-NAPHTHALEN-2-YL)-ACETYLAMINO]-BENZOIC ACID BENZOIC ACID, 3-FLUORO-4-[[(2R)-HYDROXY(5,6,7,8-TETRAHYDRO-5,5,8,8-TETRAMETHYL-2-NAPHTHALENYL)ACETYL]AMINO] |
| Description | BMS961 is a selective retinoic acid receptor-γ (RARγ) agonist. BMS961 shows anti-inflammatory activity[1]. |
|---|---|
| Related Catalog | |
| Target |
RARγ |
| In Vitro | BMS961 inhibits the expression of Dectin-1 and pro-inflammatory cytokines[1]. |
| References |
| Molecular Formula | C23H26FNO4 |
|---|---|
| Molecular Weight | 399.45500 |
| Exact Mass | 399.18500 |
| PSA | 90.12000 |
| LogP | 5.19450 |